Cancer is an aggressive disease with a low median survival rate. Ironically, the treatment
process is long and very costly due to its high recurrence and mortality rates. Accurate early …

Monitoring survival of cancer patients using data collected by population‐based cancer
registries is an important component of cancer control. In this setting, patient survival is often …

PURPOSE This guideline provides recommendations for available tissue-based prostate
cancer biomarkers geared toward patient selection for active surveillance, identification of …

Background Accurate prognostication is crucial in treatment decisions made for men
diagnosed with non-metastatic prostate cancer. Current models rely on prespecified …

Due to the lack of effective strategies on the treatment of castration resistant prostate cancer
(CRPC), we established a multifunctional nanoplatform (GNS@ IR820/DTX-CD133) for the …

Since the introduction of the hematoxylin and eosin (H&E)-stained slide in 1876 as the
primary tool in the pathologist's toolbox up until the last decade, few tools, other than the …

Abstract Background ECCO Essential Requirements for Quality Cancer Care (ERQCC) are
written by experts representing all disciplines involved in cancer care in Europe. They give …

Simple Summary Contrary to the common belief that prostate cancer is an immune desert,
our study shows tumor-associated B-cell responses in prostate cancer. We demonstrate …

In recent years, data-driven, deep-learning-based models have shown great promise in
medical risk prediction. By utilizing the large-scale Electronic Health Record data found in …

Objectives To develop a new interface for the widely used prognostic breast cancer tool:
Predict: Breast Cancer. To facilitate decision‐making around post‐surgery breast cancer …